Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II
Author:
Affiliation:
1. University of California; Los Angeles
2. University of Michigan Medical School; Ann Arbor
3. Oslo University Hospital; Oslo Norway
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Reference25 articles.
1. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies;Elhai;Rheumatology (Oxford),2012
2. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010
3. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006
4. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma;Hoyles;Arthritis Rheum,2006
5. Treatment of systemic sclerosis-related interstitial lung disease: a review of existing and emerging therapies;Volkmann;Ann Am Thorac Soc,2016
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tocilizumab in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis;Annals of the American Thoracic Society;2024-02
2. Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline;American Journal of Respiratory and Critical Care Medicine;2024-01-15
3. Approval status of essential therapeutic drugs for systemic sclerosis versus that of drugs for rheumatoid arthritis;Journal of Scleroderma and Related Disorders;2024-01-08
4. Mycophenolate in Patients with Systemic Sclerosis–associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis;Annals of the American Thoracic Society;2024-01
5. Systemic-Sclerosis-Related Interstitial Lung Disease: A Review of the Literature and Recommended Approach for Clinical Pharmacists;Annals of Pharmacotherapy;2023-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3